Investor Insight Initiates Analyst Coverage on Crdentia
11 Febbraio 2008 - 7:00PM
PR Newswire (US)
Analyst Rates Speculative Buy, $0.61 Price Target DALLAS, Feb. 11
/PRNewswire-FirstCall/ -- Crdentia Corp. (OTC:CRDT) (BULLETIN
BOARD: CRDT) , a leading healthcare staffing company, today
announced that the independent research firm Investor Insight, an
operating division of Doty-Scott Enterprises, initiated coverage on
the Company. The report is available at
http://www.crdentia.com/corporate/about/investor/ and through
http://www.dotyscott.com/ and http://www.audiostocks.com/. About
Crdentia Corp. Crdentia Corp., one of the nation's leading
providers of healthcare staffing solutions, is focused on
recruiting talented national and international healthcare
professionals to meet the ever-increasing employment needs of over
2,300 clients. Crdentia is one of the few companies that can
provide quality temporary staff for all healthcare industry
positions including local nurses, travel nurses, allied health,
locum tenens and home care professionals. For more information,
visit http://www.crdentia.com/. Forward Looking Statements
Statements contained in this release that are not historical facts
are forward-looking statements that involve risks and
uncertainties. Among the important factors which could cause actual
results to differ materially from those in the forward-looking
statements include, but are not limited to, those discussed in
"Risk Factors" in the Company's Forms 10-K, Forms 10-Q, and other
filings with the Securities and Exchange Commission. Such risk
factors include, but are not limited to, a limited operating
history with no earnings; reliance on the Company's management
team, members of which have other business interests; the ability
to successfully implement the Company's business plan; the ability
to continue as a going concern; the ability to fund the Company's
business and acquisition strategy; the growth of the temporary
healthcare professional staffing business; difficulty in managing
operations of acquired businesses; uncertainty in government
regulation of the healthcare industry; and the limited public
market for the Company's common stock. The actual results that the
Company achieves may differ materially from any forward-looking
statements due to such risks and uncertainties. Crdentia undertakes
no obligation to revise or update publicly any forward-looking
statements for any reason. Contact Crdentia Corp. John Kaiser, CEO
Phone: 972.850.0780 Fax: 972.392.2722 Jim TerBeest, CFO Phone:
972.850.0780 Fax: 972.392.2722 DATASOURCE: Crdentia Corp. CONTACT:
John Kaiser, CEO, , or Jim TerBeest, CFO, , both of Crdentia Corp.,
+1-972-850-0780, fax, +1-972-392-2722 Web site:
http://www.crdentia.com/
Copyright